Martina Godel

Via Santena 5/bis
Turin, 10126, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Correction: Kopecka et al. Insights into P-Glycoprotein Inhibitors: New Inducers of Immunogenic Cell Death. Cells 2020, 9, 1033.

Correction: Kopecka et al. Insights into P-Glycoprotein Inhibitors: New Inducers of Immunogenic Cell Death. Cells 2020, 9, 1033.

Journal: Cells
Published: April 21, 2026

Dapagliflozin enhances hemodynamic and metabolic recovery following cardioplegic arrest in the isolated working mouse heart.

Dapagliflozin enhances hemodynamic and metabolic recovery following cardioplegic arrest in the isolated working mouse heart.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 06, 2025

Correction: Belisario et al. ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma. Cells 2020, 9, 647.

Correction: Belisario et al. ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma. Cells 2020, 9, 647.

Journal: Cells
Published: December 12, 2024

Correction: TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer.

Correction: TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer.

Journal: Journal of experimental & clinical cancer research : CR
Published: August 28, 2024

Increasing membrane polyunsaturated fatty acids sensitizes non-small cell lung cancer to anti-PD-1/PD-L1 immunotherapy.

Increasing membrane polyunsaturated fatty acids sensitizes non-small cell lung cancer to anti-PD-1/PD-L1 immunotherapy.

Journal: Cancer letters
Published: May 07, 2024

TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer.

TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer.

Journal: Journal of experimental & clinical cancer research : CR
Published: March 14, 2024

Blood-brain barrier permeability increases with the differentiation of glioblastoma cells in vitro.

Blood-brain barrier permeability increases with the differentiation of glioblastoma cells in vitro.

Journal: Fluids and barriers of the CNS
Published: December 31, 2023

Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma.

Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma.

Journal: International journal of molecular sciences
Published: October 29, 2022

Electronic Coupling in 1,2,3-Triazole Bridged Ferrocenes and Its Impact on Reactive Oxygen Species Generation and Deleterious Activity in Cancer Cells.

Electronic Coupling in 1,2,3-Triazole Bridged Ferrocenes and Its Impact on Reactive Oxygen Species Generation and Deleterious Activity in Cancer Cells.

Journal: Inorganic chemistry
Published: June 14, 2022

Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer.

Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer.

Journal: Journal of experimental & clinical cancer research : CR
Published: May 23, 2022

Click ferrocenyl-erlotinib conjugates active against erlotinib-resistant non-small cell lung cancer cells in vitro.

Click ferrocenyl-erlotinib conjugates active against erlotinib-resistant non-small cell lung cancer cells in vitro.

Journal: Bioorganic chemistry
Published: October 05, 2021

Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer.

Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer.

Journal: Pharmaceutics
Published: April 12, 2021
Showing 1-12 of 16

Last Updated: 09/26/2026